First reports of adverse drug reactions Drug Reactions and Interactions 31 July 2023 Pages: 330 - 330
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents Julia PaikZaina T. Al-Salama Adis Summary of Research 29 July 2023 Pages: 317 - 318
Consider comorbidities, concomitant medications and organ function when treating chronic urticaria in older adults Tina Nie Disease Management 27 July 2023 Pages: 319 - 323
Tapinarof cream 1% in plaque psoriasis: a profile of its use Matt Shirley Adis Drug Q&A 27 July 2023 Pages: 303 - 308
Screen for drug-induced gambling disorder in vulnerable patients receiving dopaminergic drugs Simon Fung Practical Issues and Updates 21 July 2023 Pages: 297 - 301
Manage early morning ADHD symptoms and functional impairment with treatments that are effective from awakening Tina Nie Disease Management 21 July 2023 Pages: 287 - 291
Desidustat in anaemia in patients with chronic kidney disease: a profile of its use Tina NieYahiya Y. Syed Adis Drug Q&A 13 July 2023 Pages: 279 - 286
Consider new therapies for the treatment and prevention of Clostridioides difficile infection Caroline FentonConnie Kang Disease Management 07 July 2023 Pages: 237 - 242
Age is just a number with ulcerative colitis therapies Caroline FentonArnold Lee Disease Management 06 July 2023 Pages: 243 - 247
Dextromethorphan/bupropion in major depressive disorder: a profile of its use Hannah A. Blair Adis Drug Q&A 06 July 2023 Pages: 270 - 278
Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use Simon FungMatt Shirley Adis Drug Q&A 01 July 2023 Pages: 263 - 269
Manage androgenetic alopecia in men with established options but emerging therapies show promise Amy Zhuang-YanSheridan M. Hoy Practical Issues and Updates 30 June 2023 Pages: 292 - 296
Manage seborrhoeic dermatitis in older adults with customised regimens that address age-related factors Esther S. KimConnie Kang Disease Management 27 June 2023 Pages: 232 - 236
Mavacamten in obstructive hypertrophic cardiomyopathy: a profile of its use Tina NieYahiya Y. Syed Adis Drug Q&A 22 June 2023 Pages: 223 - 231
All-round approaches to increase adverse drug reaction reports: a scoping review João JoaquimCristiano MatosRamona Mateos-Campos Review Article 16 June 2023 Pages: 249 - 261
First reports of adverse drug reactions Drug Reactions and Interactions 15 June 2023 Pages: 248 - 248
Therapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines David M. HacheyBrian R. WoodAnushka Burde Therapy in Practice 12 June 2023 Pages: 216 - 221
Manage mammalian meat allergy by avoiding both the allergen and further sensitization Simon FungSheridan Hoy Practical Issues and Updates 09 June 2023 Pages: 207 - 211
Risk of falls and fractures does not necessarily preclude the use of antihypertensive medications Esther S. KimConnie Kang Drug Reactions and Interactions 25 May 2023 Pages: 212 - 215
Treat hyperhidrosis with topical therapies first, then dermatological or systemic therapies Caroline FentonConnie Kang Practical Issues and Updates 20 May 2023 Pages: 200 - 206
Common skin conditions in inflammatory bowel disease are manageable Caroline FentonArnold Lee Disease Management 16 May 2023 Pages: 191 - 194
Correction to: Mitotane in adrenocortical carcinoma: a profile of its use Matt Shirley Correction Open access 09 May 2023 Pages: 222 - 222
Be wary of adverse events when considering pharmacotherapies for spine-related pain in elderly patients Simon Fung Disease Management 05 May 2023 Pages: 178 - 182
Calcitonin gene-related peptide-targeted therapies are effective options for the prevention and treatment of migraine Tina Nie Practical Issues and Updates 05 May 2023 Pages: 195 - 199
Cognitive enhancers in healthy individuals have little benefit and significant potential harms Esther S. KimArnold Lee Practical Issues and Updates 27 April 2023 Pages: 187 - 190
Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial Julia Paik Adis Summary of Research 25 April 2023 Pages: 165 - 166
Take an individualized and multipronged approach when managing older adults with type 2 diabetes Sheridan M. Hoy Disease Management 11 April 2023 Pages: 171 - 177
Management of ulcer-related pain requires optimal wound treatment, and potentially, analgesics Arnold Lee Practical Issues and Updates 10 April 2023 Pages: 183 - 186
Colchicine may be considered for the secondary prevention of cardiovascular disease Esther S. KimArnold Lee Disease Management 27 March 2023 Pages: 167 - 170
The treatment of post-traumatic nightmares requires more attention Esther S. KimConnie Kang Disease Management 22 March 2023 Pages: 125 - 130
An overview of recent US-approved gene therapies for Duchenne muscular dystrophy and their respective clinical development programs Dale Yu Review Article 21 March 2023 Pages: 156 - 163
Treat bladder dysfunction in older patients with established agents, but botulinum toxin type A may have a role Caroline FentonConnie Kang Practical Issues and Updates 21 March 2023 Pages: 141 - 146
Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature Fatima AlsalamaSalma AlzaabiBassam Atallah Review Article 02 March 2023 Pages: 147 - 155
Prescribe proton pump inhibitors with care and be aware of the signs of nephrotoxicity Tina NieYoung-A Heo Drug Reactions and Interactions 24 February 2023 Pages: 131 - 135
Nivolumab/relatlimab in advanced melanoma: a profile of its use Arnold Lee Adis Drug Q&A 21 February 2023 Pages: 89 - 95
Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management Caroline FentonConnie Kang Practical Issues and Updates 17 February 2023 Pages: 107 - 113
Manage methamphetamine-associated cardiomyopathy by promoting abstinence in addition to the use of pharmacotherapies Simon FungArnold Lee Practical Issues and Updates 15 February 2023 Pages: 136 - 140
The role of community pharmacists in optimising patient self-management of constipation: an inter-disciplinary consensus view Thomas FrielingEric MartinChristian Ude Current Opinion Open access 31 January 2023 Pages: 114 - 123
Ganaxolone in seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: a profile of its use in the USA Susan J. KeamZaina T. Al-Salama Adis Drug Q&a 30 January 2023 Pages: 81 - 88
First reports of adverse drug reactions Drug Reactions and Interactions 26 January 2023 Pages: 57 - 57
Growth-related effects of antiseizure medications are of concern in children with epilepsy Esther S. KimArnold Lee Drug Reactions and Interactions 26 January 2023 Pages: 96 - 101
Take a fresh look at diet and atopic dermatitis Caroline FentonArnold Lee Practical Issues and Updates 24 January 2023 Pages: 102 - 106
Avacopan in granulomatosis with polyangiitis and microscopic polyangiitis: a profile of its use Sheridan M. Hoy Adis Drug Q&a 20 December 2022 Pages: 48 - 56
Methodically manage pain in older patients with Parkinson’s disease Caroline FentonArnold Lee Practical Issues and Updates 13 December 2022 Pages: 58 - 64
Antidepressants with anti-inflammatory properties may be useful in long COVID depression Caroline FentonArnold Lee Practical Issues and Updates 12 December 2022 Pages: 65 - 70
Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges Irena Preloznik ZupanKarla RenerSasa Anzej Doma Original Research Article Open access 08 December 2022 Pages: 71 - 80
Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy Hui-Lee WongRongmei ZhangDavid J. Graham Original Research Article 06 December 2022 Pages: 29 - 39
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use Hannah A. Blair Adis Drug Q&a 06 December 2022 Pages: 41 - 47
Correction to: Amantadine extended release capsules (GOCOVRI®) in Parkinson’s disease: a profile of its use in the USA Zaina T. Al-Salama Correction Open access 29 November 2022 Pages: 40 - 40
Limit acne damage with lasers and light therapy Caroline FentonConnie Kang Practical Issues and Updates 24 November 2022 Pages: 20 - 25